{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T17:35:14Z","timestamp":1769708114883,"version":"3.49.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Lupus erythematosus (LE) encompasses a spectrum of autoimmune diseases with significant heterogeneity, ranging from cutaneous lupus erythematosus (CLE), confined to the skin, to systemic lupus erythematosus (SLE), which affects multiple internal organs. The underlying pathogenesis of lupus skin lesions and the heterogeneity among various subtypes remain elusive and require further investigation. This review synthesizes recent progress in elucidating the mechanisms of lupus skin injury, providing novel perspectives on diagnosis and therapeutic strategies, while also outlining promising avenues for future investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Key insights include the active pathogenic role of keratinocytes, essential involvement of neutrophils, the central role of type I interferon (IFN-I) signaling, and a preactivated molecular state in nonlesional skin. Emerging distinctions between CLE and SLE lesions, as well as the role of photosensitivity, are also examined. These findings highlight modifiable environmental factors as critical parts for LE prevention and establish a new paradigm for future precision medicine in LE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>These novel findings enrich the complex pathogenic network underlying lupus skin injury, accelerating the transition toward precision medicine. Rational prevention, early diagnosis, and targeted treatment represent the core principles and a promising vision for the future evolution of lupus management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000001139","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T02:00:10Z","timestamp":1764381610000},"page":"100-106","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pathogenesis of skin damage in lupus: recent advances and future directions"],"prefix":"10.1097","volume":"38","author":[{"given":"Qilin","family":"Li","sequence":"first","affiliation":[{"name":"Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College"},{"name":"Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences"},{"name":"Jiangsu Provincial Key Laboratory of Dermatololgy, Nanjing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianjin","family":"Lu","sequence":"additional","affiliation":[{"name":"Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College"},{"name":"Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences"},{"name":"Jiangsu Provincial Key Laboratory of Dermatololgy, Nanjing"},{"name":"Department of Dermatology, Second Xiangya Hospital, Central South University, Hunan Key Laboratory of Medical Epigenomics, Changsha, Hunan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"R1-20260129","doi-asserted-by":"crossref","first-page":"e70246","DOI":"10.1002\/mco2.70246","article-title":"New mechanisms and therapeutic targets in systemic lupus erythematosus","volume":"6","author":"Tian","year":"2025","journal-title":"MedComm"},{"key":"R2-20260129","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","article-title":"Autoimmunity and organ damage in systemic lupus erythematosus","volume":"21","author":"Tsokos","year":"2020","journal-title":"Nat Immunol"},{"key":"R3-20260129","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11926-020-00893-9","article-title":"An update on the pathogenesis of skin damage in lupus","volume":"22","author":"Li","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"R4-20260129","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/BOR.0000000000000739","article-title":"Cutaneous and systemic connections in lupus","volume":"32","author":"Maz","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"R5-20260129","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/bjd\/ljae183","article-title":"Concomitant moderate-to-severe cutaneous lesions have marked impact on quality of life in patients with active systemic lupus erythematosus: a cross-sectional insight from two phase III randomized clinical trials in adults","volume":"191","author":"Mallbris","year":"2024","journal-title":"Br J Dermatol"},{"key":"R6-20260129","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41584-025-01267-0","article-title":"Immunometabolism in systemic lupus erythematosus","volume":"21","author":"Pati\u00f1o-Martinez","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"R7-20260129","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.molmed.2024.11.002","article-title":"The molecular underpinnings of female predominance in lupus","volume":"31","author":"Kosmara","year":"2025","journal-title":"Trends Mol Med"},{"key":"R8-20260129","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41590-024-01898-7","article-title":"The immunology of systemic lupus erythematosus","volume":"25","author":"Tsokos","year":"2024","journal-title":"Nat Immunol"},{"key":"R9-20260129","doi-asserted-by":"crossref","first-page":"1341272","DOI":"10.3389\/fgene.2024.1341272","article-title":"Genetic interrogation for sequence and copy number variants in systemic lupus erythematosus","volume":"15","author":"Yeo","year":"2024","journal-title":"Front Genet"},{"key":"R10-20260129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41423-024-01254-7","article-title":"Increasing evidence for the pathogenic role of keratinocytes in lupus","volume":"22","author":"Klein","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"R11-20260129","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40257-023-00774-8","article-title":"Cutaneous lupus erythematosus: an update on pathogenesis and future therapeutic directions","volume":"24","author":"Niebel","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"R12-20260129","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1038\/s41467-020-19918-z","article-title":"Functionally impaired plasmacytoid dendritic cells and nonhaematopoietic sources of type I interferon characterize human autoimmunity","volume":"11","author":"Psarras","year":"2020","journal-title":"Nat Commun"},{"key":"R13-20260129","doi-asserted-by":"crossref","first-page":"7908","DOI":"10.1038\/s41598-020-64865-w","article-title":"The early local and systemic Type I interferon responses to ultraviolet B light exposure are cGAS dependent","volume":"10","author":"Skopelja-Gardner","year":"2020","journal-title":"Sci Rep"},{"key":"R14-20260129","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jid.2016.09.008","article-title":"Lupus skin is primed for IL-6 inflammatory responses through a keratinocyte-mediated autocrine type I interferon loop","volume":"137","author":"Stannard","year":"2017","journal-title":"J Invest Dermatol"},{"key":"R15-20260129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.07.007","article-title":"A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus","volume":"93","author":"Li","year":"2018","journal-title":"J Autoimmun"},{"key":"R16-20260129","first-page":"575","article-title":"Emerging concepts of type I interferons in SLE pathogenesis and therapy","volume":"18","author":"Psarras","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"R17-20260129","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41392-025-02168-0","article-title":"Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics","volume":"10","author":"Dai","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"R18-20260129","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/cup.14736","article-title":"Immunohistochemical expression of immune regulatory proteins in interface dermatoses","volume":"52","author":"McAlpine","year":"2025","journal-title":"J Cutan Pathol"},{"key":"R19-20260129","doi-asserted-by":"crossref","first-page":"eabn2263","DOI":"10.1126\/scitranslmed.abn2263","article-title":"Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation","volume":"14","author":"Billi","year":"2022","journal-title":"Sci Transl Med"},{"key":"R20-20260129","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.4049\/jimmunol.0902514","article-title":"Lupus serum IgG induces skin inflammation through the TNFR1 signaling pathway","volume":"184","author":"Deng","year":"2010","journal-title":"J Immunol"},{"key":"R21-20260129","doi-asserted-by":"crossref","first-page":"127291","DOI":"10.1172\/jci.insight.127291","article-title":"The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity","volume":"4","author":"Billi","year":"2019","journal-title":"JCI Insight"},{"key":"R22-20260129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41423-024-01240-z","article-title":"Dysregulation in keratinocytes drives systemic lupus erythematosus onset","volume":"22","author":"Tian","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"R23-20260129","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/1346-8138.17036","article-title":"Role of neutrophils in cutaneous lupus erythematosus","volume":"51","author":"Yamamoto","year":"2024","journal-title":"J Dermatol"},{"key":"R24-20260129","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/exd.14040","article-title":"Investigating the presence of neutrophil extracellular traps in cutaneous lesions of different subtypes of lupus erythematosus","volume":"28","author":"Safi","year":"2019","journal-title":"Exp Dermatol"},{"key":"R25-20260129","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard-2022-223741","article-title":"Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets","volume":"82","author":"Crow","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R26-20260129","doi-asserted-by":"crossref","first-page":"eaax1159","DOI":"10.1126\/scitranslmed.aax1159","article-title":"PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus","volume":"11","author":"Han","year":"2019","journal-title":"Sci Transl Med"},{"key":"R27-20260129","first-page":"1792","article-title":"Neutrophils impaired by antigalectin-3 antibodies elicit inflammation of endothelial cells to aggregate the development of lupus cutaneous vasculitis","volume":"42","author":"Hu","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"R28-20260129","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.3389\/fimmu.2019.02428","article-title":"Blue and long-wave ultraviolet light induce in vitro neutrophil extracellular trap (NET) formation","volume":"10","author":"Neubert","year":"2019","journal-title":"Front Immunol"},{"key":"R29-20260129","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2019097118","article-title":"Acute skin exposure to ultraviolet light triggers neutrophil-mediated kidney inflammation","volume":"118","author":"Skopelja-Gardner","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"R30-20260129","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jid.2023.10.039","article-title":"Plasmacytoid dendritic cells are not major producers of type 1 IFN in cutaneous lupus: an in-depth immunoprofile of subacute and discoid lupus","volume":"144","author":"Vazquez","year":"2024","journal-title":"J Invest Dermatol"},{"key":"R31-20260129","doi-asserted-by":"crossref","first-page":"20373","DOI":"10.1038\/srep20373","article-title":"Phenotypic and functional alterations of pDCs in lupus-prone mice","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci Rep"},{"key":"R32-20260129","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.immuni.2018.03.020","article-title":"Self-renewal and toll-like receptor signaling sustain exhausted plasmacytoid dendritic cells during chronic viral infection","volume":"48","author":"Macal","year":"2018","journal-title":"Immunity"},{"key":"R33-20260129","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-025-02234-3","article-title":"TNF and type I interferon crosstalk controls the fate and function of plasmacytoid dendritic cells","volume":"26","author":"Arroyo Hornero","year":"2025","journal-title":"Nat Immunol"},{"key":"R34-20260129","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1084\/jem.20132620","article-title":"Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model","volume":"211","author":"Rowland","year":"2014","journal-title":"J Exp Med"},{"key":"R35-20260129","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa2118024","article-title":"Trial of anti-BDCA2 antibody litifilimab for cutaneous lupus erythematosus","volume":"387","author":"Werth","year":"2022","journal-title":"N Engl J Med"},{"key":"R36-20260129","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-025-09513-x","article-title":"Loss-of-function mutations in PLD4 lead to systemic lupus erythematosus","author":"Wang","year":"2025","journal-title":"Nature"},{"key":"R37-20260129","first-page":"2170","article-title":"Prevalence and characteristics of, and knowledge related to, photosensitivity in patients with lupus erythematosus: the international PHOTOLUP study","volume":"63","author":"Battesti","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"R38-20260129","doi-asserted-by":"crossref","first-page":"103393","DOI":"10.1016\/j.jaut.2025.103393","article-title":"Exploring the correlation between UVB sensitivity and SLE activity: insights into UVB-driven pathogenesis in lupus erythematosus","volume":"153","author":"He","year":"2025","journal-title":"J Autoimmun"},{"key":"R39-20260129","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/annrheumdis-2018-213197","article-title":"Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa","volume":"77","author":"Sarkar","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R40-20260129","doi-asserted-by":"crossref","DOI":"10.1002\/art.43273","article-title":"Loss of TRIM21 drives UVB-induced systemic inflammation by regulating DNA-sensing pathways","author":"Tumurkhuu","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"R41-20260129","doi-asserted-by":"crossref","first-page":"eado1710","DOI":"10.1126\/sciimmunol.ado1710","article-title":"Epidermal ZBP1 stabilizes mitochondrial Z-DNA to drive UV-induced IFN signaling in autoimmune photosensitivity","volume":"10","author":"Klein","year":"2025","journal-title":"Sci Immunol"},{"key":"R42-20260129","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168412","article-title":"Lymphatic dysfunction in lupus contributes to cutaneous photosensitivity and lymph node B cell responses","volume":"135","author":"Howlader","year":"2025","journal-title":"J Clin Invest"},{"key":"R43-20260129","doi-asserted-by":"crossref","first-page":"103203","DOI":"10.1016\/j.jaut.2024.103203","article-title":"Multiomics study reveals different pathogenesis of the generation of skin lesions in SLE and IDLE patients","volume":"146","author":"Li","year":"2024","journal-title":"J Autoimmun"},{"key":"R44-20260129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3899\/jrheum.220089","article-title":"Cutaneous involvement in systemic lupus erythematosus: a review for the rheumatologist","volume":"50","author":"Stull","year":"2023","journal-title":"J Rheumatol"},{"key":"R45-20260129","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1038\/s41467-022-35209-1","article-title":"Single-cell sequencing shows cellular heterogeneity of cutaneous lesions in lupus erythematosus","volume":"13","author":"Zheng","year":"2022","journal-title":"Nat Commun"},{"key":"R46-20260129","doi-asserted-by":"crossref","first-page":"102391","DOI":"10.1016\/j.jaut.2019.102391","article-title":"Disordered cutaneous microbiota in systemic lupus erythematosus","volume":"108","author":"Huang","year":"2020","journal-title":"J Autoimmun"},{"key":"R47-20260129","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jid.2019.11.016","article-title":"Staphylococcus aureus colonization is increased on lupus skin lesions and is promoted by IFN-mediated barrier disruption","volume":"140","author":"Sirobhushanam","year":"2020","journal-title":"J Invest Dermatol"},{"key":"R48-20260129","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/art.43079","article-title":"Topical mupirocin treatment reduces interferon and myeloid signatures in cutaneous lupus erythematous lesions through targeting of Staphylococcus species","volume":"77","author":"Abernathy-Close","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"R49-20260129","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/jdv.20031","article-title":"Human-multimodal deep learning collaboration in \u2019precise\u2019 diagnosis of lupus erythematosus subtypes and similar skin diseases","volume":"38","author":"Li","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R50-20260129","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41584-023-00948-y","article-title":"Precision medicine in systemic lupus erythematosus","volume":"19","author":"Fasano","year":"2023","journal-title":"Nat Rev Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001139","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T06:00:27Z","timestamp":1769666427000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001139","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]}}}